|
|
| SPIRIT III: Trial designed to compare Abbott’s XIENCE V Everolimus Eluting Coronary Stent System with Boston Scientifi |
SPIRIT III: Trial designed to compare Abbott’s XIENCE V Everolimus Eluting Coronary
Stent System with Boston Scientific's TAXUS Paclitaxel-Eluting Coronary Stent System Gregg
W. Stone, MD
Sponsorship for the booth and interviews at ACC 2007 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from the Medicines Company,
Merck, Schering-Plough and Scios.
[ Download video ] |
|
No comments have been submitted
|